http://pharmtech.findpharma.com/pharmtech/Manufacturing/President-Obamas-State-of-the-Union-Address-Favora/ArticleStandard/Article/detail/705896?contextCategoryId=40939(...)
GPhA supported the President’s call for lowering the federal budget deficit and reducing healthcare expenditures. “As the President noted, addressing the long-term deficit ‘means further reducing healthcare costs, including programs like Medicare and Medicaid, which are the single biggest contributor to our long-term deficit,’” said GPhA in a Jan. 25, 2011, press release. “Increasing the use of generic drugs has proven over and over again to be the solution to holding down healthcare spending.”
Meanwhile, SOCMA, which represents batch and custom manufacturers, including contract manufacturers of active pharmaceutical ingredients and intermediates, supported the President’s call for regulatory reform for businesses. “Allowing companies to invest in their businesses to develop new products is key,” said SOCMA President and CEO Lawrence D. Sloan, in a Jan. 25, 2011, SOCMA press release. “Innovation creates opportunity and prosperity while regulation consumes them. SOCMA members are living testament to this circumstance as they manufacture highly specialized products that take years through research and development to produce.”
Sloan also supported the President’s call to pass free-trade agreements. “Congress needs to approve without delay the agreements with South Korea, Colombia, and Panama,” said Sloan. “Opening up more markets to trade not only makes economic sense, it will directly benefit SOCMA members’ unique products and improve their competitiveness.”
Printer-friendly format
Email this thread to a friend
Bookmark this thread
(1000+ posts)
Send PM |
Profile |
Ignore
